Silva Arslanian, MD
Disclosures: Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca|Grant or research support-Eli Lilly and Company|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Eli Lilly and Company|Grant or research support-Novo Nordisk|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novo Nordisk - 12/01/2021
THE 2ND INTERNATIONAL NOVO NORDISK SYMPOSIUM ON

 

 

SILVA ARSLANIAN, M.D.

Biography

 

 

Silva Arslanian, M.D., is Professor of Pediatrics, and Professor of Clinical and Translational Science Institute at the University of Pittsburgh, School of Medicine. She holds the Richard L. Day Endowed Chair in Pediatrics, at the UPMC Children’s Hospital of Pittsburgh. She is the Director of the National Institutes of Health (NIH)-funded Pediatric Clinical and Translational Research Center, and the Scientific Director of the Center for Pediatric Research in Obesity & Metabolism at the University of Pittsburgh, UPMC Children's Hospital of Pittsburgh.

 

Dr. Arslanian obtained her medical degree from the American University of Beirut and completed her pediatric residency training at the same institution. She completed her fellowship in Pediatric Endocrinology at the UPMC Children’s Hospital of Pittsburgh.

 

Dr. Arslanian is funded by NIH, Research Foundations and Pharmaceutical Companies. Her research focus is insulin sensitivity and beta cell function during childhood growth and development, in health and disease (obesity, prediabetes, Type 2 diabetes, metabolic syndrome, PCOS), and racial contrast in risk for the aforementioned. She has been a major contributor to landmark studies including TODAY (Treatment Options for Type 2 Diabetes in Adolescents and Youth) and RISE (Restoring Insulin SEcretion). She has served the national and international scientific communities in various capacities. Dr. Arslanian is the recipient of several prestigious awards for her seminal contributions in advancing scientific discoveries in youth type 2 diabetes, pediatric insulin resistance and beta cell function. She has more than 250 publications and has been a highly sought-after lecturer and chairperson at various national and international congresses.